Eureka Forbes Q1FY27: consolidated PAT +47% flattered by one-off; OPM slips to 9.9%
PAT +47.26% YoY · revenue +15.22% · margins compressing
₹700.4 Cr
+15.22% YoY
₹56.99 Cr
+47.26% YoY
8.05%
+1.8pp YoY
₹2.93
Eureka Forbes reported consolidated revenue from operations of ₹700.4 Cr for Q1 FY27 (quarter ended June 30, 2026), up 15.2% YoY from ₹607.9 Cr and up 2.4% QoQ from ₹683.7 Cr. Consolidated PAT came in at ₹57.0 Cr, up 47.3% YoY and 11.7% QoQ, with basic EPS of ₹2.93 versus ₹1.99 a year ago. No Q1FY27-specific brokerage consensus could be located — the results were only approved by the board today; the only market estimate found was Trendlyne's full-year FY27 consensus (13 analysts) of roughly 13.5% revenue growth and 44.7% PAT growth, which is a full-year figure and not a valid single-quarter benchmark, so vsStreet is marked unknown rather than inferred.
Q1 FY-2027 vs prior quarters
The PAT headline is flattered by a one-off: during the quarter the company amended its gratuity scheme to align with the Payment of Gratuity Act, 1972, and the resulting actuarial remeasurement produced a ₹19.54 Cr reversal of gratuity expense, booked as an exceptional item (identical amount in both standalone and consolidated). Stripping that out, profit before exceptional items and tax was ₹57.1 Cr, and adjusted PAT works out to roughly ₹42.5 Cr — putting underlying YoY PAT growth at approximately +9.7%, well below the reported +47.3% and also trailing the 15.2% revenue growth, meaning operating leverage worked against the company this quarter. That shows up directly in the operating margin: OPM (revenue-based operating profit margin, unaffected by the exceptional item) compressed to 9.9% from 10.1% a year ago and fell sharply from 12.5% in Q4 FY26. This runs counter to management's Q4 FY26 concall guidance to "at least hold margins in FY27 despite cost inflation" — on this quarter's print that commitment was not met, even though the volume-led revenue growth they targeted did materialise.
The stock went into the print at ₹465.6, down 0.7% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 2 consecutive quarters.
What the summary numbers don't show
Reported NPM 8.05% vs 7.41% (Q4FY26) and 6.29% (Q1FY26) is largely one-off driven; adjusted NPM of ~6.0% is roughly flat YoY.
Management provided guidance indicating an expectation to step up revenue growth in FY27, with a primary focus on volume expansion rather than pricing. They aim to at least hold margins in FY27 despite cost inflation, leveraging efficiency programs and a diversified portfolio. Long-term guidance remains firm, targeting
— This quarter: missed
No management press release accompanied this filing, so there is no fresh commentary to cross-check against the numbers beyond the standard board disclosures. Alongside the results, promoter entity Lunolux Midco disclosed encumbrance of 62.55% of its stake and Catalyst Trusteeship separately disclosed a pledge of 11.4 million shares in the weeks before the results — a shareholding/governance datapoint worth flagging, though unrelated to this quarter's operating performance. Employee costs this quarter also carried a ₹6.66 Cr (₹665.96 lakh) ESOP share-based payment charge under Ind AS 102.
W1
Whether OPM recovers toward the ~12%+ level seen in Q4FY26 or stabilises near 10%, against management's commitment to at least hold margins in FY27.
W2
Whether the 15.2% YoY, volume-led revenue growth pace sustains through FY27 toward the long-term FY30 targets across water purifiers, robotics, air purifiers, water softeners and filters.
W3
Whether Q2FY27 PAT growth reverts to the ~9-10% adjusted underlying run-rate now that the ₹19.5 Cr one-off gratuity reversal will not repeat.
Both standalone and consolidated PBT/PAT carry a ₹19.54 Cr exceptional gain (reversal of gratuity expense from a scheme amendment to the Payment of Gratuity Act, 1972) — excluded in adjustedPatYoYPct. NCI ~₹0.01 Cr, immaterial. Converted from ₹ Lakh to ₹ Cr (÷100). Unaudited, subject to limited review only.
15% Growth, 6% Profit—Where Eureka Forbes' Leverage Went
Reported earnings pop 47% on a one-time gratuity reversal. Strip that, and pre-exceptional profit is up just 6%—revealing a company trading margin for growth with profit leverage risk baked into FY30 targets.
₹57.0 Cr
+47.3% YoY
₹41.0 Cr
+6.1% YoY
₹700.4 Cr
+15.2% YoY
6.1% vs 15.2%
Material shortfall
On the headline, Eureka Forbes' Q1 profit surged 47.3% to ₹57 crore—a pop that signals momentum. Strip the one-time gratuity reversal gain of approximately ₹16 crore, and pre-exceptional profit sits at ₹41 crore, up just 6.1% against 15.2% revenue growth. That gap is the quarter's real story: a company trading margin for growth, and not yet generating the profit leverage needed to support its FY30 ambitions (2x revenue, 3x EBITDA). The market saw it clearly: post-result the stock fell 1.95% on day 1 and extended to −4.42% by day 3.
Where the profit came from
Management claims checked against the result
Revenue grew 15.3% YoY to ₹701 Cr
Delivered ₹700.4 Cr at 15.2% YoY growth
Supported
Water purifier grew by high teens with double-digit volume growth
Product business high-teens growth confirmed; exact water purifier % not separately disclosed
Supported
Pre-exceptional PAT grew 6.1% YoY to ₹41 Cr
Reported PAT ₹57 Cr includes ~₹16 Cr one-time gratuity reversal. Pre-exceptional indeed ₹41 Cr (+6.1%)
Supported but concerning
EBITDA margin 10.5%, down 46 bps with growth investments
Confirmed; gross margin also down 131 bps from commodity/forex. Margin compression structural, not cyclical
Supported; signal negative
Service revenue in line with prior quarters despite 3-12% price hike
Confirmed at ~2.7% growth YoY; bookings softer due to customer deferrals
Supported; growth decelerated
Market share gains in water despite competitive intensity
Stated by management; no external verification. Organic growth vs. supply-constrained competitors is narrative
Supported but unvalidated
What changed on this call
Three strategy shifts reveal underlying pressure: First, service double-digit growth guidance quietly vanished. Prior calls expected service to accelerate; now management reframes as 'two drivers' (AMC + filters) with no numeric commitment—a silent downgrade. Second, FY27 margin guidance is to 'hold' (not expand), despite a prior FY26 call promising margin expansion on efficiency. A 15% revenue quarter typically drives margin expansion; management's defensive posture signals either compressed pricing power or intractable cost headwinds. Third, efficiency programs are now the margin lever—AI, data-driven waste elimination, cost clinicals—a signal that pricing is capped and operational excellence is the only path forward.
The market's verdict: sell-off and position trim
Post-result, the stock fell 1.95% on day 1, extending to −4.42% by day 3. Today it trades at ₹419.85, down 37.18% from its all-time high of ₹668.3, and below its 20-day (₹447.08), 50-day (₹454.26), and 200-day (₹511.1) moving averages. RSI sits at 34.8 (neutral). Foreign institutional investors—the marginal buyer—trimmed their stake 41bp quarter-on-quarter to 13.25%, the second consecutive trim. On a 15% revenue quarter, the price action and flow don't lie: the market agrees that headline growth masks margin pressure and profit-leverage risk.
The bull case
Solid 15.2% revenue growth, broad-based across water, robotics, emerging categories
Water purifiers growing high-teens with double-digit volume; market share gains noted
Robotics, air purifiers, softeners all accelerating; ₹1,000 Cr robotics ambition by FY30
D2C platform at 2.5M monthly active users; cross-sell to 15M customer base largely untapped (<1% multi-category ownership)
Net cash ₹425 Cr; strong balance sheet for long-term investments and strategic moves
FY26 track record: started -46 bps margins, ended +55 bps; management can expand on scale
The bear case is equally substantive:
Pre-exceptional PAT growth only 6.1% vs revenue 15.2%—critical leverage gap at the start of FY27
Gross margin down 131 bps YoY; commodity/forex headwinds persistent with 'no meaningful relief expected in FY27'
EBITDA margin down 46 bps; guidance to 'hold' (not expand) signals no near-term upside despite growth
Service revenue at ~2.7% growth; bookings soft post 3-12% AMC price hike; recovery timeline uncertain
A&SP spending up 21.4%, outpacing 15.2% revenue growth; operating leverage not materializing yet
Pricing power capped; management explicitly avoiding further hikes to protect growth momentum
Ranked risks (for a holder)
Profit leverage collapse
HighPAT growing 6.1% vs revenue 15.2% is a material execution shortfall. If this gap persists, FY30 targets (3x EBITDA on 2x revenue) are at material risk. Efficiency programs must close it, and Q1 shows they haven't yet.
Gross margin structural compression
HighDown 131 bps YoY with 'no meaningful relief' expected in FY27. Commodity/forex headwinds ongoing. Cost-saving programs the only lever. Limited pricing power to offset. Margin floor is the key unknown.
Service deferral and recovery timing
Medium-HighAMC bookings soft post price hike. Management expects 'normalization over time' tied to 18-month tenure lag. If deferral is structural (customers switching/downtrading), profit impact is larger than forecast. Deferred liability provides tailwind but not solution.
Competitive intensity in water purifiers
MediumNew entrants emerging and matching filter-life innovations (competitors matched Eureka's Q1 move within 30 days). Market share gains now; pricing power eroding. Need innovation velocity to sustain share in a growing category.
Emerging category scaling execution
MediumRobotics ₹1,000 Cr by FY30 (40%+ CAGR) is ambitious. Market still nascent; competitive entry likely as size grows. D2C advantage is real but not durable against well-funded entrants. Execution on premiumization and retail expansion critical.
The debate
What to watch next
1 · Pre-exceptional PAT in Q2 FY27
Must re-accelerate closer to revenue growth rate (ideally >12%) to validate margin guidance and FY30 profit targets. If it remains the number to track.
2 · Service revenue recovery (Q2–Q3 FY27)
Watch for normalization from ~2.7% growth post price-hike deferral window. Target to beat: 8%+ growth by Q3 to signal sustainable trajectory. If service remains <5%, deferral was deeper than management admits.
3 · Gross margin stabilization (H2 FY27)
Commodity/forex relief unlikely, so success = cost-saving programs delivering offsets. Target to beat: get back to 59%+ by Q4 to show margin floor holds. Operating leverage must show up in efficiency, not just on revenue.
The close
Eureka Forbes is a solid, consistent franchisee with market leadership in water purifiers and credible long-term ambitions. But Q1 FY27 reveals a company caught in the middle of two forces: revenue accelerates (15.2%), but profit limps (6.1% pre-exceptional). The one-time gratuity gain masked the gap; post-result, the market called it—FII trimmed, the stock sold 4.42% by day 3, and it's now down 37% from all-time high.
Until pre-exceptional PAT growth matches revenue growth—or management raises profit guidance on the back of emerging category scale—the stock remains vulnerable to higher interest rates and earnings disappointment. Efficiency programs and operating leverage must deliver. Margin guidance to 'hold' (not expand) in a 15% growth quarter is not confidence-building.
For a holder: monitor Q2 pre-exceptional PAT (target >12%) and service recovery (target >8%). For a potential buyer: wait for evidence that profit leverage is repairing. The number to track from here is organic PAT in Q2. It will tell whether this is Q1 upfront investment (as management argues) or a structural margin squeeze that caps upside to FY30 targets.
Strong growth masks profit shortfall; margin maintained, not raised
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Pre-exceptional PAT growth 6.1% vs revenue 15.2% signals execution gap. Guidance maintained (not raised) despite 15% growth.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered solid 15% revenue growth, but pre-exceptional PAT growth of only 6.1% reveals weak profit leverage. Despite cost headwinds and margin compression (-46 bps EBITDA, -131 bps gross), management maintains (not raises) FY27 margin guidance, suggesting limited upside near-term. Long-term 2x revenue/3x EBITDA targets by FY30 are credible (emerging categories, D2C, innovations), but profit execution risk remains the key constraint.
₹700.4 Cr
Revenue · +15.2% YoY₹57 Cr
Reported PAT · +47.3% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 15.3% YoY to ₹701 Cr
METDelivered ₹700.4 Cr, 15.2% YoY growth
Water purifier grew by high teens with double-digit volume growth
METProduct business high-teens growth confirmed; exact water purifier % not separately disclosed by company
Adjusted EBITDA margin 10.5%, down 46 bps YoY with higher growth investments
METConfirmed; also noted gross margin down 131 bps from commodity/forex impact
Pre-exceptional PAT grew 6.1% YoY to ₹41 Cr
METReported PAT ₹55 Cr includes ₹19.5 Cr one-time gratuity reversal gain. Pre-exceptional ₹41 Cr = 6.1% growth only
Service revenue growth in line with past quarters despite 3-12% price hike
METConfirmed; bookings softer due to customer deferrals. Service revenue growth ~2.7% in absolute terms
Market share gains in water despite competitive intensity
METManagement stated market share gained, but no external data to verify; organic growth vs supply-constrained competitors
Earnings quality
What changed since the last call
Margin guidance: hold, not expand
MaintainedPrior FY26 guidance said hold margins in FY27 despite cost inflation. Current call reaffirms 'broadly in line with last year.' No margin expansion target despite 15% revenue growth.
Service growth deflated post-pricing
DowngradePrior calls implied double-digit service growth. Q1: service revenue ~2.7% growth; bookings deferred due to 3-12% AMC price hike. Normalization expected but timeline uncertain.
Cost environment: no relief visibility
NeutralManagement states 'cost environment remains challenging, yet to see meaningful reduction in input costs.' Commodities, forex, geopolitics ongoing. Efficiency programs the only lever.
Emerging categories thrust intensified
UpgradeRobotics, softeners, air purifiers all growing ahead of average. Robotics ₹1,000 Cr ambition by FY30 (up from early-stage). New campaign featuring Shraddha Kapoor launched.
D2C momentum sustained
New2.5M monthly active users, strong growth. Cross-sell to 15M customer base underway. Low multi-category ownership (<1%) creates upside.
The Q&A
Moderate. Analysts pressed on service weakness (deferral vs loss), pricing strategy amid cost inflation, and margin sustainability. Management defended: service deferral temporary (18-month lag effect), pricing calibrated to protect growth momentum, margin maintenance achievable via efficiency + operating leverage. No major evasions, but lack of numeric commitments on near-term PAT growth.
Service growth pressure — Siddhartha Bera, Nomura
PartialService bookings deferred due to price hike; expect normalization over time. Filter business growth compensating. Deferred liability from prior multiyear AMCs to benefit FY27 revenue.
Pricing strategy and cost coverage — Siddhartha Bera, Nomura
AnsweredCalibrated, measured approach. While not covering 100% of cost increase in percentage terms, covered in absolute terms. Focus on efficiency, cost savings programs, portfolio mix.
A&SP spend breakdown — Siddhartha Bera, Nomura
PartialDon't break out by quarter. Almost entire increase is A&SP, largely in-store presence and retail visibility investments.
Growth composition (price vs volume) — Keshav Lahoti, HDFC Securities
AnsweredWater: double-digit volume growth with some price impact. Robotics: mix shift to premium (premiumization). Softeners: volume-led. Overall broad-based, volume-led.
Service double-digit guidance withdrawn — Keshav Lahoti, HDFC Securities
DodgedTwo drivers: AMC and filters. Bookings softer but filters growing well. Timeline for double-digit recovery depends on bookings and filter scaling.
Filter life innovation response — Umang Mehta, Kotak Securities
AnsweredWe were first to 2-year, then 4-year (45 days ago). Focus on TCO reduction and category growth. 70% of 2-year customers are first-time entrants.
A&SP spend guidance — Achal Lohade, Nuvama
PartialDon't disclose quarterly breakout. Expect A&SP ahead of revenue growth for full year. Focused on in-store presence and consumer finance adoption.
Service liability and margin impact — Achal Lohade, Nuvama
AnsweredLiability helps FY27 revenue. Softer bookings help service charges somewhat but not large profitability impact. Filters slightly lower margin than AMC but still high GM.
Market share gains organic? — Sameer Gupta, IIFL Capital
AnsweredNo supply constraint benefit. Competitive field. Gained share via strong consumer propositions, point-of-sale investments, disciplined execution.
Margin trajectory FY27 — Sameer Gupta, IIFL Capital
AnsweredQ1 conscious upfront investment in growth. Multiple workstreams on COGS and opex efficiency. Operating leverage from higher growth. Prior year started -46 bps, ended +55 bps expansion.
FY30 revenue growth mix — Vikram Kotak, Ace Lansdowne
AnsweredProduct and emerging categories growing ahead of average. Service (AMC + filters) also part of 2x. Filters large TAM with upside. Mix may shift.
Robotics 3-year outlook — Vikram Kotak, Ace Lansdowne
AnsweredAnalogous to washing machines 25-30 years ago. Full portfolio (₹15k–₹1L), India-specific features, service network moat, brand equity, D2C database, offline presence all key advantages.
FY30 revenue split across segments — Mayur Parkeria, Wealth Managers
PartialWater core, emerging categories (robotics, air, softeners) ahead of average. Service includes AMC + filters; filters to grow ahead of AMC. Overall 2x.
FY27 margin expansion vs 50 bps annual plan — Mayur Parkeria, Wealth Managers
AnsweredLast 3 years margins consistently improved. This year unusual (commodity, forex, geopolitics). Holding margins is good outcome. Next year bigger scale allows make-up.
Competitive defense strategy — Anjali Mohata, Melania Family Office
AnsweredMore competition grows category. Focus on affordability (entry + TCO), premiumization, innovation. Category leader mandate is consumer-obsessed, not competitor-focused.
Historical growth rate vs aggressive targets — Anjali Mohata, Melania Family Office
AnsweredFY23 had little category growth. FY24 onwards initiatives (affordable Aquaguard, awareness) drove acceleration. Category accelerating. Product growth to exceed 17-18% overall target.
Operational efficiency plans — Anjali Mohata, Melania Family Office
AnsweredFocused, deliberate planned intervention on waste reduction and efficiency. Clinical review of all costs. Using technology, data, AI to find efficiency gains.
Guidance
FY27: clear step-up in growth vs FY26 baseline
MediumSpecific number not provided. Q1 at 15.2% sets pace. Depends on service recovery and emerging category scale.
FY30: 2x revenue vs FY25 (CAGR 17-18%)
HighReaffirmed multiple times. Product categories (esp. water, robotics, softeners, air) to grow ahead of average.
FY27 EBITDA margins: broadly in line with FY26
MediumMaintain, not expand. Q1 down 46 bps YoY; expects recovery in later quarters via operating leverage + efficiency programs.
FY30: 3x EBITDA vs FY25
MediumContingent on revenue growth + margin leverage. Currently PAT growth lagging revenue; profit execution risk present.
Risks the call surfaced
Service revenue pressure
HighService bookings softer post 3-12% AMC price hike. Customers deferring renewals. Recovery timeline tied to 18-month AMC tenure lag.
Gross margin compression
HighGross margin down 131 bps YoY to 58.4% due to commodity costs and adverse currency movements. Cost environment 'challenging' with 'no meaningful reduction expected.'
Profit leverage risk
MediumPre-exceptional PAT growth only 6.1% vs revenue 15.2%. Despite 15% revenue growth, PAT severely lagging. Margin guidance to 'hold' (not expand) suggests limited near-term profit upside.
Pricing power constrained
MediumManagement states will NOT raise prices further despite cost inflation. Peers matched Q1 price hike with ~30-day lag; 'price equilibrium' now restored. Bias toward growth over margin protection.
Emerging category scaling risk
MediumRobotics, air purifiers, softeners still nascent (low base). Management targets ₹1,000 Cr robotics by FY30 (5-year CAGR ~40%+). Ambitious. Competitive entry likely as market grows.
Management
Score 7/10. Clear on strategy and long-term vision. Candid on near-term headwinds (service deferral, cost inflation). Avoided specific near-term PAT targets; focused on 'step-up' language. Q&A responses detailed, generally direct. FY26 track record positive: started with -46 bps margin, ended with +55 bps expansion. Q1 FY27 revenue 15.2% on target, but pre-exceptional PAT only 6.1% signals execution gap on profit. Service bookings weak as flagged.
1 · Q2-Q3 FY27
Service bookings normalization post price-hike deferral window
2 · FY28
Emerging categories (robotics, softeners) scaling to higher base; margin leverage from volume
3 · Near-term
Commodity/forex headwinds persist; no relief expected in FY27
Long-term 2x revenue/3x EBITDA targets by FY30 are credible (emerging categories, D2C, innovations), but profit execution risk remains the key constraint.
Tracking momentum: Q1 growth acceleration test as Street cheers FY30 ambition
Eureka Forbes enters Q1 FY27 with strong consensus expectations and a margin-expansion roadmap. Analysts look to validate accelerating revenue growth and the trajectory toward ₹5,400–5,600 Cr revenue by FY30, while recent promoter pledges add a sideshow to watch.
What to expect: the on-plan setup
Eureka Forbes is not forecast to miss FY27's top-line expectations. The company delivered 11.3% revenue growth in FY26 and posted its best-ever EBITDA margin (13.2%) in Q4. Analysts now expect Q1 FY27 to flex that momentum, with Street consensus at 13.5% full-year revenue growth and a 44.7% profit growth forecast for the fiscal year. A strong Q1 reading would confirm the company is tracking its FY30 ambition (₹5,400–5,600 Cr revenue, triple EBITDA from FY26 base).
~₹768 Cr
On-plan: FY27 consensus guides 13.5% growth vs. Q1 FY26 base of ~₹677 Cr
~12.8–13.0%
Track record: FY26 margin 12.2%, Q4 expanded to record 13.2%; management committed to maintain or expand
Service + products
Water purifiers double-digit; AMC (after-market care) bookings sustaining double-digit momentum; new filters and emerging categories unlocked
A strong print would show Q1 revenue in the ₹760–₹790 Cr range with EBITDA margin holding above 12.8%, validated by management commentary on service-segment traction, product-mix shift toward higher-margin categories, and reaffirmed FY30 guidance. A weak print would signal revenue below ₹740 Cr or EBITDA margin dipping below 12.2%, raising questions on the pace of new-category adoption (filters, emerging verticals) and the sustainability of double-digit service growth amid seasonal headwinds.
Street consensus & the debate
On track: prior trajectory
Eureka Forbes has logged back-to-back double-digit revenue growth (11.3% in FY26) and expanded EBITDA margin for three straight years. Q4 FY26 marked the pinnacle: 11.6% revenue growth paired with a record 13.2% EBITDA margin. The company guided for accelerated growth in FY27 (13.5% consensus) while pointing to structural margin uplift from service-business momentum (double-digit AMC bookings) and new product categories. Q1 FY27 will be the first test of whether management can deliver on that acceleration without sacrificing the margin trajectory the Street has come to expect.
Since last quarter: filings & corporate actions
1 · Promoter share encumbrance disclosure (Aug 5–7)
Lunolux Midco Limited (promoter, holding 62.55%) revised disclosures under SEBI takeover regs, confirming encumbrance of its entire 62.55% stake effective May 7, 2026. Status: routine under-the-hood security arrangement; no change to voting control. Monitor for any escalation in pledge levels or asset-backing changes, but no red flag from the filings alone.
2 · Catalyst Trusteeship pledge (Jul 31)
Catalyst Trusteeship Ltd (onshore security agent for Lunolux lenders) disclosed a top-up pledge of 11.42M shares (~5.90% of issued capital). This is a lender-protective measure tied to Lunolux debt arrangements; does not signal financial distress but worth monitoring if fresh pledges layer.
3 · 17th AGM scheduled for Aug 19, 2026
Annual General Meeting to approve FY26 accounts and governance resolutions. Conducted via video conferencing; no unusual agenda items flagged in filings.
4 · Trading window closure (Jun 25)
Trading window closed for employees & insiders ahead of Q1 FY27 result; opens post board approval on Aug 12. Routine compliance; no insider-buying signals detected.
The promoter pledges are not operationally adverse—they reflect debt-financing arrangements at the holding company level and do not alter voting control or strategic direction. Aggregate pledging is material (~68% of issued shares combined, per recent disclosures) but common for family-owned industrial businesses; flag for monitoring but no trigger to downgrade the print.
What to watch on result day: August 12
1 · Revenue growth pace: is it tracking 13.5% FY27 guidance?
Look for Q1 revenue in the ₹760–₹790 Cr zone (13–15% YoY growth). Weakness below ₹740 Cr would raise questions on consumer discretionary softness and new-category ramp. Management commentary on water-purifier market share, emerging categories (filters, smart home), and B2B/B2C channel mix will be critical.
2 · EBITDA margin: maintaining the 13%+ trajectory
Q4's record 13.2% margin set a high bar. Expect management to guide for steady-state margin in the 12.8–13.2% range for FY27 amid input-cost volatility. Margin beat would signal pricing power and product-mix shift toward service (higher margin); miss below 12.2% could indicate temporary cost pressures.
3 · Service-business momentum: are AMC bookings sustaining double-digit growth?
This is the hidden engine. Recurring-revenue stream (AMC) commands premium margins and underpins margin-expansion story. Any softening in AMC traction or churn would be a material red flag for FY30 ambitions.
4 · Product portfolio uplift: filters and emerging categories
Management highlighted unlocking the filters opportunity in recent calls. Q1 commentary on filters revenue, penetration rate, and product-mix contribution will show whether this is a minor accretion or a material growth lever.
Eureka Forbes enters Q1 FY27 with strong Street backing (Strong Buy, 36–55% target upside) and clear on-plan expectations: ~₹768 Cr revenue on 13.5% growth, EBITDA margin holding above 12.8%, and service-segment momentum intact. The company has delivered back-to-back double-digit revenue growth and expanded margin for three years running; Q1 will be the first test of whether that acceleration trajectory holds in FY27. Recent promoter-pledge disclosures are routine lender-protective measures, not operational red flags.
The result on August 12 hinges on three things: (1) revenue growth pace (₹760–₹790 Cr would be on-plan), (2) EBITDA margin (12.8%+ is the bar), and (3) service-business color (AMC double-digit growth = confidence in FY30 targets). A beat on all three would reset Street expectations upward; miss on margin or service traction would force a rethink on the ₹5,400–5,600 Cr FY30 revenue target and justify the 32% pullback from all-time highs.